Fact CheckerSign in

NCT06196866Active, not recruiting

Effectiveness of Exergaming in Adittion to Conventional Treatment for Physical Therapy in People with Multiple Sclerosis

Effectiveness of Two Different Exergaming Systems in Addition to Conventional Treatment for Physical Therapy in Patients with Multiple Sclerosis: a Study Protocol for a Multicenter, Assessor-blind, 24-week, Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 7 Mar 2025

Brief summary (registry, in English)

The present study aims to evaluate the effectiveness of two different exergaming systems in addition to conventional treatment on physical functional capacity, balance, muscle strength, spasticity in lower limbs and quality of life compared to an isolated conventional intervention in patients with multiple sclerosis. The secondary aim will be to compare the differences between both exergaming groups.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
36 (actual)
First submitted
24 Dec 2023
Start date
1 Sept 2023
Primary completion date
31 Oct 2024
Lead sponsor
Universidad de Córdoba
NCT number
NCT06196866

What you commit to

  • Study type: Interventional
  • Participants enrolled: 36
  • From 1 Sept 2023 to the primary completion date, 31 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • (ii) Exacerbation or steroid treatment in the 30 days prior to inclusion in the study.

Other illness

  • (i) Diagnosis of another disease that affects balance and/or coordination.

Other

  • (iii) Presence of visual deficits.

Who the study is looking for

  • (i) Diagnosis of MS in any of its types (clinically isolated syndrome, relapsing-remitting MS, primary progressive MS or secondary progressive MS) based on the McDonald criteria.
  • (ii) Age over 18 years.
  • (iii) Mini-Mental State Examination score \> 19 points.
  • (iv) Score on the Expanded Disability Status Scale (EDSS) under 7.0 points.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Cordoba
Coordinator of this site? Confirm its status
CórdobaSpainUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.